MDAI vs. FONR, NSPR, VANI, PDEX, BLAC, SEPA, SURG, STIM, CTSO, and MODD
Should you be buying Spectral AI stock or one of its competitors? The main competitors of Spectral AI include FONAR (FONR), InspireMD (NSPR), Vivani Medical (VANI), Pro-Dex (PDEX), Bellevue Life Sciences Acquisition (BLAC), SEP Acquisition (SEPA), SurgePays (SURG), Neuronetics (STIM), Cytosorbents (CTSO), and Modular Medical (MODD). These companies are all part of the "medical equipment" industry.
Spectral AI (NASDAQ:MDAI) and FONAR (NASDAQ:FONR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, community ranking, profitability, analyst recommendations and risk.
FONAR received 171 more outperform votes than Spectral AI when rated by MarketBeat users. However, 100.00% of users gave Spectral AI an outperform vote while only 73.93% of users gave FONAR an outperform vote.
In the previous week, Spectral AI had 8 more articles in the media than FONAR. MarketBeat recorded 10 mentions for Spectral AI and 2 mentions for FONAR. Spectral AI's average media sentiment score of 0.83 beat FONAR's score of 0.43 indicating that Spectral AI is being referred to more favorably in the media.
Spectral AI presently has a consensus price target of $3.75, suggesting a potential upside of 109.50%. Given Spectral AI's higher possible upside, equities research analysts clearly believe Spectral AI is more favorable than FONAR.
FONAR has a net margin of 10.66% compared to Spectral AI's net margin of 0.00%. FONAR's return on equity of 7.50% beat Spectral AI's return on equity.
FONAR has higher revenue and earnings than Spectral AI.
67.1% of Spectral AI shares are held by institutional investors. Comparatively, 50.6% of FONAR shares are held by institutional investors. 56.7% of Spectral AI shares are held by company insiders. Comparatively, 2.2% of FONAR shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Spectral AI has a beta of 0.61, indicating that its stock price is 39% less volatile than the S&P 500. Comparatively, FONAR has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500.
Summary
Spectral AI beats FONAR on 8 of the 15 factors compared between the two stocks.
Get Spectral AI News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDAI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MDAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Spectral AI Competitors List
Related Companies and Tools
Free MDAI Stock Alerts